Substance Abuse

Injection Drug Users in Methadone Treatment More Likely to Reduce Risk Behaviors

Published in Medical Letter on the CDC and FDA, December 10th, 2000

Injection drug users who stay in methadone treatment, or who interrupt and return to treatment, engage in fewer behaviors that increase risk of acquiring hepatitis viruses or HIV, public health researchers report.

In Seattle-King County, Washington, data were collected on 716 injection drug users (IDUs) who had entered methadone treatment with regard to their injecting habits, compliance with and retention in treatment, and their hepatitis B and/or C status. Questionnaires were completed at the start of the study and again at 12-months follow-up. Blood samples of IDUs in treatment were tested for HIV, hepatitis B, and hepatitis C.

Hanne Thiede and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2000-12-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry